U.S. Stock Futures Show Rally Likely to Pause This Week 
 

Treasury's decision to allow emergency Fed programs to expire raises uncertainty about economic support as coronavirus surges, investors said.


 
Job Market Growth Slows Across U.S. as Covid-19 Cases Surge 
 

Midwestern states, where infection rates are high, are seeing growth in daily job postings stall. But other states are also seeing a slowdown.


 
Lumber Prices Rise Again 
 

Lumber prices are making an unusual late-season climb, thanks to builder-friendly autumn weather and suppliers stocking up for what they expect to be another big year for home construction.


 
Mnuchin Declines to Extend Several Fed Emergency Lending Programs 
 

Treasury Secretary Steven Mnuchin declined to extend several emergency loan programs established jointly with the Federal Reserve that are set to expire on Dec. 31.


 
Fannie, Freddie Overseer Looks to End Federal Control Before Trump Leaves 
 

The federal regulator who oversees Fannie Mae and Freddie Mac is pushing to speed up the mortgage giants' exit from 12 years of government control but has yet to reach an agreement he needs with Treasury Secretary Steven Mnuchin, according to people familiar with the matter.


 
U.S. Infections Set Another Daily Record 
 

The U.S. reported 187,833 new cases for Thursday, according to data compiled by Johns Hopkins University, exceeding its last daily record by more than 10,000.


 
Think Tank Urges Financial Sector Action on Cyber Threats 
 

Despite decades of heavy investment in cybersecurity, the global financial system remains vulnerable to cyberattack because banks and regulators fail to coordinate their activities, a report from a leading think tank said Wednesday.


 
Suffering Emerging Markets Can Bounce Back From the Depths 
 

Better-than-expected news on vaccines and global growth prospects next year will mean an opportunity for battered equities in developing economies outside East Asia to stage a recovery.


 
WHO Recommends Against Use of Gilead Covid-19 Drug Remdesivir 
 

The World Health Organization said there isn't evidence that the antiviral drug reduces deaths or recovery times for patients suffering from the coronavirus.


 
FDA to Get Application for First Covid-19 Vaccine Friday 
 

A vaccine partnership involving Pfizer and German company BioNTech plans to file with the Food and Drug Administration Friday for possible FDA clearance of a vaccine, according to Health and Human Services Secretary Alex Azar.

(END) Dow Jones Newswires

11-20-20 0915ET